{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-084062","form_type":"8-K","ticker":"KTTA","cik":"0001841330","company_name":"Pasithea Therapeutics Corp.","filed_at":"2025-09-03T23:59:59+00:00","discovered_at":"2026-05-14T18:02:45.300168+00:00","generated_at":"2026-05-17T08:38:38.630731+00:00","sec_items":["5.02","5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Pasithea shareholders approve reverse split authorization (1:2–1:20) and 1.75M share increase for equity plan","bullets":["Stockholders approved reverse stock split of common stock at ratio from 1:2 to 1:20, at Board discretion, valid through September 2026.","Shareholders approved amendment to 2023 Stock Incentive Plan, increasing authorized shares by 1.75M to 2,014,221 shares.","Ratified CBIZ CPAs P.C. as independent auditor for FY2025 with 3.40M for, 39K against, 52K abstain.","Re-elected Alfred Novak (1.31M for) and Simon Dumesnil (1.29M for) as Class II directors, terms expiring 2028.","Quorum of 3.5M of 7.4M outstanding shares represented at the meeting; no other business."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-084062","json":"https://secwatch.observer/filing/0001213900-25-084062.json","markdown":"https://secwatch.observer/filing/0001213900-25-084062.md","text":"https://secwatch.observer/filing/0001213900-25-084062.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1841330/000121390025084062/0001213900-25-084062-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1841330/000121390025084062/ea0255742-8k_pasithea.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T08:38:38.630731+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}